Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) was the target of a significant decrease in short interest during the month of August. As of August 15th, there was short interest totalling 551,100 shares, a decrease of 8.0% from the July 31st total of 599,300 shares. Based on an average daily volume of 65,300 shares, the short-interest ratio is presently 8.4 days. Approximately 4.2% of the company’s shares are sold short.
Analyst Upgrades and Downgrades
Separately, StockNews.com began coverage on Accelerate Diagnostics in a report on Tuesday. They set a “hold” rating for the company.
Get Our Latest Analysis on Accelerate Diagnostics
Institutional Trading of Accelerate Diagnostics
Accelerate Diagnostics Trading Down 1.4 %
NASDAQ:AXDX opened at $1.97 on Wednesday. The firm has a market capitalization of $43.44 million, a price-to-earnings ratio of -0.48 and a beta of 0.57. Accelerate Diagnostics has a 1-year low of $0.73 and a 1-year high of $7.06. The business’s fifty day moving average price is $1.42 and its 200 day moving average price is $1.17.
Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The medical research company reported ($0.50) EPS for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.05. The company had revenue of $2.99 million for the quarter, compared to analyst estimates of $3.00 million. Equities analysts forecast that Accelerate Diagnostics will post -2.14 earnings per share for the current year.
About Accelerate Diagnostics
Accelerate Diagnostics, Inc, an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms.
See Also
- Five stocks we like better than Accelerate Diagnostics
- How to Effectively Use the MarketBeat Ratings Screener
- Nordstrom’s Winning Formula: 3 Factors Behind the Stock’s Success
- The 3 Best Fintech Stocks to Buy Now
- How to See Stocks the Way Warren Buffett Sees Stocks
- What is a Bond Market Holiday? How to Invest and Trade
- 3 No-Brainer Stocks to Buy and Hold Long-Term
Receive News & Ratings for Accelerate Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accelerate Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.